Applied StemCell Inc, a leading CRO/CDMO recognized for its proprietary TARGATT gene editing technology and expertise in stem cells and cell therapy development, is pleased to announce the addition of two accomplished professionals to its C-level executive team: George Hong (Chief Commercial Officer) and Timothy J. Largen (Chief Operating Officer)
Company Information
Company
Applied StemCell
Location
521 Cottonwood Drive
Milpitas, California, United States
About
Applied StemCell is a biotechnology company founded in 2008 to empower industry and academic researchers with cutting-edge gene editing and induced pluripotent stem cell (iPSC) technologies. Today, the company continues to drive the discovery and development of advanced therapeutics with a strong focus on genome engineering products and services. Backed by patented technologies, Applied StemCell provides a clear intellectual property path to commercialization, enabling innovation across the life sciences sector.
Fundz sees it the moment Applied StemCell changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.